Showing results (201-210 of 34,619) with videos related to
Sort By:
Pageof 3,462
Cancer|July 15, 2010
A double-blind, randomized trial of pyridoxine versus placebo for the prevention of pegylated liposomal doxorubicin-related hand-foot syndrome in gynecologic oncology patientsVivian von Gruenigen, Heidi Frasure, Nancy Fusco, et al.Cancer|July 15, 2010
Critical role of surgery in patients with gastroesophageal carcinoma with a poor prognosis after chemoradiation as defined by positron emission tomographySrikrishna V Patnana, Santosh B Murthy, Lianchun Xiao, et al.Cancer|July 15, 2010
Phase 1-2 trial of PTK787/ZK222584 combined with intravenous doxorubicin for treatment of patients with advanced hepatocellular carcinoma: implication for antiangiogenic approach to hepatocellular carcinomaThomas Yau, Pierre Chan, Roberta Pang, et al.Cancer|July 15, 2010
BRAF, a target in melanoma: implications for solid tumor drug developmentKeith T Flaherty, Grant McArthurCancer|July 31, 2010
Osteosarcoma in very young children: experience of the Cooperative Osteosarcoma Study GroupLeo Kager, Andreas Zoubek, Martin Dominkus, et al.Cancer|July 15, 1991
Enhancement of tumor-associated glycoprotein-72 antigen expression in hormone-related ovarian serous borderline tumorsH E Cajigas, E Fariza, R E Scully, et al.Cancer|August 31, 2010
Assessment of HER2 gene status in breast carcinomas with polysomy of chromosome 17Semir Vranic, Bryan Teruya, Susan Repertinger, et al.Cancer|August 31, 2010
Endoscopic esophageal tumor length: a prognostic factor for patients with esophageal cancerPuja Gaur, Boris Sepesi, Wayne L Hofstetter, et al.Cancer|August 25, 2010
How does initial treatment choice affect short-term and long-term costs for clinically localized prostate cancer?Claire F Snyder, Kevin D Frick, Amanda L Blackford, et al.Cancer|August 25, 2010
Estimating recurrences prevented from using trastuzumab in HER-2/neu-positive adjuvant breast cancer in the United StatesMark D Danese, Deepa Lalla, Melissa Brammer, et al.Pageof 3,462